Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.
about
Gammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodentsIncidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosisHepatitis C virus: epidemiology and genotypes in the north east of England.The clinical virology of hepatitis C virusViruses as co-factors for the initiation or exacerbation of lung fibrosisViruses in Idiopathic Pulmonary Fibrosis. Etiology and ExacerbationAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementTreatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab.Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.Nonhepatic manifestations and combined diseases in HCV infection.Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C.Recent advances in the aetiology of cryptogenic fibrosing alveolitis.Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disordersHerpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionThe epidemiology of interstitial lung disease and its association with lung cancer.Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection.Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosisDeterminants of initiation and progression of idiopathic pulmonary fibrosis.Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibody.The complex interrelationships between chronic lung and liver disease: a review.Relationship between hepatitis C virus infection and pulmonary disorders: potential mechanisms of interaction.Idiopathic pulmonary fibrosis-an epidemiological and pathological review.Viral infection and aging as cofactors for the development of pulmonary fibrosis.Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.Studying human respiratory disease in animals--role of induced and naturally occurring models.Advances in the treatment of idiopathic pulmonary fibrosis.Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiationSystemic abnormalities in liver disease.Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection?Idiopathic pulmonary fibrosis and hepatitis C virus infection.Case-control study of medical history and idiopathic pulmonary fibrosis in Japan.Usefulness of the serum KL-6 assay in patients with hepatitis C virus.Inflammatory myopathy and hepatitis C virus infection.Sicca syndrome associated with hepatitis C virus infection.Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection.
P2860
Q26829291-93EFB06B-1CDB-4AA9-BF04-208520AA61B6Q27469497-7F2AF7AA-9E64-42D7-9335-9E60A1531CFDQ27473017-80EB56DB-355F-4DE0-AAA4-5C3EFE26892FQ27481239-12997523-1C5A-42F9-86CD-9BD2D54D769FQ27487313-F31A302F-1329-4C9A-A730-E9EF5D7B3DDCQ28081676-A9B886CE-61AD-48F3-B56D-CB88E56FD0D0Q28308246-38CC5808-99D3-417C-A13E-3CAEAECC9A39Q33364746-EDC304CC-008D-4E8C-A06F-1CE88605A5BFQ33378075-A3EE6F52-BEE0-4BD5-8B07-963F63B264F1Q33498313-15F2C934-6FED-4098-B017-E114992BCCB0Q33775924-517CB20E-3298-4CD9-895D-80C7AFE853BFQ33901227-C688071B-89B6-41E9-B871-110A752450B7Q34105545-F7AD01C8-CDC7-4E57-9A56-5D35309BC02DQ34998351-7D0DF8D6-2EC7-4F96-BCA4-ABB114F7C289Q35027515-078D4E3B-44F1-4CFE-A65B-1BE09628B450Q35731058-F9B2B5BA-A4F8-4FA7-9922-E9924F6FA493Q35875981-50A39315-EBC6-41AF-A046-70ACB981FD97Q36496266-E79C6101-6104-42F3-81EC-30C4B8F13D04Q37002839-C4E1461E-97E4-4AA9-8F68-114F7E893D0DQ37263917-9CC74C13-BC7D-4697-B21E-623E6B8FCAB3Q37362701-7E60BB80-B13C-43BB-A227-56B3F1874EEDQ37594222-A2CD742D-C440-45BB-BA62-B9A41643EEF5Q37660988-DAA37E7F-9ECA-4BFD-A6E4-192737F080C7Q37729353-DA93CAD3-D64D-4126-9007-B50BBA75D8DDQ37755272-AFB3BE90-F63A-4E3D-A0C3-E6D93A752D66Q37788591-FAACFB84-AB00-410D-8B63-0F4D775D8D26Q37815487-9ED26215-81BE-4235-A950-17184B6D9103Q38059610-AAC3D72B-6B8E-45E2-B9A3-84F94D50B1FDQ38607416-C3C597DC-0D97-4D96-8508-29EABCAF8133Q38656594-CE5967C7-46F1-497E-AB04-E474B3400404Q38914780-C123BFE7-F806-469E-9147-508197C52ED6Q41713855-AA60C017-8902-404B-AB86-7ECB30737D1CQ42623529-406F5741-3376-45E5-9869-CD96F080F226Q42774333-7E4A10DD-62AB-4B0A-9DCB-E11A6DC54BCDQ43035239-29059F8F-236C-4C3C-A68E-951A46716381Q44906294-6B6FDFB0-C8D8-4C3E-BA17-3DD27EFB7B85Q45435671-9244CE2E-6E8A-4DED-BC9C-C780B0EAB334Q45754843-305B7773-1064-492C-94EC-B044BB6C9A93Q45770092-27F5930E-C53F-45EE-AEBE-3B804870FC37Q45770348-40BEDE1B-09D6-4FDD-83AD-18382246F4BA
P2860
Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@en
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@nl
type
label
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@en
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@nl
prefLabel
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@en
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@nl
P2093
P356
P1476
Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.
@en
P2093
Horiuchi T
Miyamoto T
Watanabe J
Yamaguchi M
P304
P356
10.1164/AJRCCM/146.1.266
P577
1992-07-01T00:00:00Z